NCT00151515View on ClinicalTrials.gov

A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss

PHASE3CompletedINTERVENTIONAL
Enrollment

352

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Androgenetic Alopecia
Interventions
DRUG

minoxidil

Topical 5% minoxidil foam, BID, for sixteen weeks

Trial Locations (15)

17033

Pfizer Investigational Site, Hershey

27701

Pfizer Investigational Site, Durham

44101

Pfizer Investigational Site, Cleveland

45202

Pfizer Investigational Site, Cincinnati

55401

Pfizer Investigational Site, Minneapolis

55421

Pfizer Investigational Site, Fridley

75201

Pfizer Investigational Site, Dallas

78701

Pfizer Investigational Site, Austin

80012

Pfizer Investigational Site, Denver

84101

Pfizer Investigational Site, Salt Lake City

92037

Pfizer Investigational Site, La Jolla

94102

Pfizer Investigational Site, San Francisco

94503

Pfizer Investigational Site, Vallejo

97201

Pfizer Investigational Site, Portland

06510

Pfizer Investigational Site, New Haven

All Listed Sponsors
lead

Johnson & Johnson Consumer and Personal Products Worldwide

INDUSTRY

NCT00151515 - A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss | Biotech Hunter | Biotech Hunter